PRDX1 and oral cavity squamous cell carcinoma: In addition, low expression of PRDX1 indicated the risk of tumor progression and correlated significantly with reduced survival in oral squamous cell carcinoma [19], cholangiocarcinoma [21], esophageal squamous cell carcinoma [46], and pancreatic adenocarcinoma [23].